Tolerance and Efficacy of Subcutanous Low Doses Rituximab for CLL Consolidation Treatment
Clinical trial NCT01521689 · UNKNOWN
Trial details
- NCT number
- NCT01521689
- Sponsor
- Institut Paoli-Calmettes
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2015-06-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.